Guselkumab binding to CD64+IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling.
R. Atreya,M. T. Abreu,J. G. Krueger,K. Eyerich, C. Greving,D. Hammaker, B. Stoveken, J. Hartman, K. Leppard,I. Sarabia, J. Wertheimer, J. Deming, K. Kohler, H. Li, T. Freeman, A. Hart, B. Keyes,C. Ritchlin,I. B. McInnes,M. Allez, A. Fourie, K. Sachen JOURNAL OF CROHNS & COLITIS（2024）
AI 理解论文
溯源树
样例
